News

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Use of high-risk antibiotics is linked to C diff infections, but the class of antibiotics with the strongest link has changed over time underscoring the need for ongoing assessment.

The Contagion® editorial staff will be providing exclusive written and video coverage from IDWeek 2019.

According to results from the Rwanda Population-based HIV Impact Assessment (RPHIA), 76% of all adults living with HIV in Rwanda have achieved viral load suppression.

The FDA has approved treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis that shortens duration of treatment to 8 weeks.

A hospital sheds light on how dogs can help identify C diff contamination.

Investigators of a new study assessed data from a 14-year-period and found that the prevalence ratio for heart infections related to drug abused jumped from 8% to 16%.

Investigators used national electronic health record data to determine the proportion of American adults who have been tested for HIV.

A human vaccine could reach clinical trials in 2 years, the lead researcher told Contagion®.

Amid growing reports of viral resistance in patients living with HIV, IDSA, HIV Medicine Association, and American Academy of HIV Medicine have issued a joint policy paper.

The storm damaged multiple public health clinics and vector-borne diseases remain a concern, per a PAHO/WHO report.

In part 1 of our Q&A with Fair, we talk about his background, education, and experience, and also how the outbreak response to the current Ebola outbreak in the DRC differs from traditional disaster response.

The approval marks the first FDA-approved, non-replicating smallpox vaccine, and the only FDA-approved vaccine for prevention of monkeypox.

The vaccine, manufactured by Johnson & Johnson, is administered in 2 doses, 56 days apart and will be used in areas that are not experiencing active transmission.

Long-term immunogenicity of a 2-dose schedule of the quadrivalent HPV vaccination was demonstrated in a new study in Canada that followed up on an earlier clinical trial.

USPSTF has downgraded its recommendation regarding the screening of pregnant women for asymptomatic bacteriuria, based on reduced applicability of the previous evidence.

A new paper offers a compelling theory as to why it takes so long for antibiotics to defeat tuberculosis.

A 10th human case of EEE in Massachusetts has also become the state’s second fatality, the state Department of Public Health has announced.

A National Influenza Vaccine Task Force has been established, which will develop a 5-year plan to promote new vaccine manufacturing technology and to accelerate the development of a universal flu vaccine.

Jump-starting HIV treatment in hospital emergency department settings could be a key to curbing the spread of the virus.

“We want the readers to know that there is room for improvement in current hand hygiene regimen,” the study authors said.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of September 15, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Antibiotic treatment for more than 20 months may cause lasting changes in the gut microbiota of preterm infants, a new study suggests.

The outbreak was declared after a 3-year-old girl tested positive for vaccine-derived polio virus type 2.

The approval allows treatment-experienced adults living with HIV who are virally suppressed to switch to doravirine or doravirine/lamivudine/tenofovir disoproxil fumarate.

Along with other heart ailments, new research finds that people living with HIV have a greater risk of atrial fibrillation.